BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 22768734)

  • 41. Treatment for diabetic mononeuropathy with alpha-lipoic acid.
    Tankova T; Cherninkova S; Koev D
    Int J Clin Pract; 2005 Jun; 59(6):645-50. PubMed ID: 15924591
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Efficacy and safety of high-dose α-lipoic acid in the treatment of diabetic polyneuropathy].
    Gu XM; Zhang SS; Wu JC; Tang ZY; Lu ZQ; Li H; Liu C; Chen L; Ning G
    Zhonghua Yi Xue Za Zhi; 2010 Sep; 90(35):2473-6. PubMed ID: 21092474
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The effect of alpha-lipoic acid on the neurovascular reflex arc in patients with diabetic neuropathy assessed by capillary microscopy.
    Haak ES; Usadel KH; Kohleisen M; Yilmaz A; Kusterer K; Haak T
    Microvasc Res; 1999 Jul; 58(1):28-34. PubMed ID: 10388600
    [TBL] [Abstract][Full Text] [Related]  

  • 44. alpha-Lipoic acid decreases oxidative stress even in diabetic patients with poor glycemic control and albuminuria.
    Borcea V; Nourooz-Zadeh J; Wolff SP; Klevesath M; Hofmann M; Urich H; Wahl P; Ziegler R; Tritschler H; Halliwell B; Nawroth PP
    Free Radic Biol Med; 1999 Jun; 26(11-12):1495-500. PubMed ID: 10401614
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Alpha-lipoic acid protects against hepatic ischemia-reperfusion injury in rats.
    Dulundu E; Ozel Y; Topaloglu U; Sehirli O; Ercan F; Gedik N; Sener G
    Pharmacology; 2007; 79(3):163-70. PubMed ID: 17259747
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Influence of treatment of diabetic rats with combinations of pycnogenol, beta-carotene, and alpha-lipoic acid on parameters of oxidative stress.
    Berryman AM; Maritim AC; Sanders RA; Watkins JB
    J Biochem Mol Toxicol; 2004; 18(6):345-52. PubMed ID: 15674846
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [The use of dipyridamole (curantyl) in combination with alpha-lipoic acid in the treatment of diabetic neuropathy with retinopathy].
    Al-Zamil MKh
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(7):23-6. PubMed ID: 18833114
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Alpha-lipoic acid in diabetic neuropathy. Action mechanism and therapy. Clinical picture and pathogenesis of diabetic neuropathy].
    Internist (Berl); 1994 Jun; 35(6 Alpha-liponsa):1-4. PubMed ID: 9532228
    [No Abstract]   [Full Text] [Related]  

  • 49. Endothelial dysfunction in type 2 diabetes: effect of antioxidants.
    Sena CM; Nunes E; Louro T; Proença T; Seiça RM
    Rev Port Cardiol; 2007 Jun; 26(6):609-19. PubMed ID: 17849945
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Alpha-lipoic--dihydrolipoic acids--active bioantioxidant and bioregulatory system].
    Baraboĭ VA
    Ukr Biokhim Zh (1999); 2005; 77(3):20-6. PubMed ID: 16566124
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Alpha-lipoic acid treatment ameliorates metabolic parameters, blood pressure, vascular reactivity and morphology of vessels already damaged by streptozotocin-diabetes.
    Koçak G; Aktan F; Canbolat O; Ozoğul C; Elbeğ S; Yildizoglu-Ari N; Karasu C;
    Diabetes Nutr Metab; 2000 Dec; 13(6):308-18. PubMed ID: 11232755
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The effectiveness of treatments of diabetic autonomic neuropathy is not the same in autonomic nerves supplying different organs.
    Shotton HR; Clarke S; Lincoln J
    Diabetes; 2003 Jan; 52(1):157-64. PubMed ID: 12502507
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Pathomechanism of diabetic neuropathy: background of the pathogenesis-oriented therapy].
    Winkler G; Kempler P
    Orv Hetil; 2010 Jun; 151(24):971-81. PubMed ID: 20519180
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficacy and safety of alpha-lipoic acid supplementation in the treatment of symptomatic diabetic neuropathy.
    Foster TS
    Diabetes Educ; 2007; 33(1):111-7. PubMed ID: 17272797
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Attenuation of myocardial apoptosis by alpha-lipoic acid through suppression of mitochondrial oxidative stress to reduce diabetic cardiomyopathy.
    Li CJ; Zhang QM; Li MZ; Zhang JY; Yu P; Yu DM
    Chin Med J (Engl); 2009 Nov; 122(21):2580-6. PubMed ID: 19951573
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Metabolic effects of gamma-linolenic acid-alpha-lipoic acid conjugate in streptozotocin diabetic rats.
    Khamaisi M; Rudich A; Beeri I; Pessler D; Friger M; Gavrilov V; Tritschler H; Bashan N
    Antioxid Redox Signal; 1999; 1(4):523-35. PubMed ID: 11233149
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evidence for using alpha-lipoic acid in reducing lipoprotein and inflammatory related atherosclerotic risk.
    Harding SV; Rideout TC; Jones PJ
    J Diet Suppl; 2012 Jun; 9(2):116-27. PubMed ID: 22607646
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Advances in the studies of lipoic acid in male infertility].
    Zhang GW; Liu W; Shang XJ
    Zhonghua Nan Ke Xue; 2017 Jan; 23(1):82-86. PubMed ID: 29658244
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Fructose-induced inflammation, insulin resistance and oxidative stress: A liver pathological triad effectively disrupted by lipoic acid.
    Castro MC; Massa ML; Arbeláez LG; Schinella G; Gagliardino JJ; Francini F
    Life Sci; 2015 Sep; 137():1-6. PubMed ID: 26188590
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Role of α-lipoic acid in LPS/d-GalN induced fulminant hepatic failure in mice: studies on oxidative stress, inflammation and apoptosis.
    Xia X; Su C; Fu J; Zhang P; Jiang X; Xu D; Hu L; Song E; Song Y
    Int Immunopharmacol; 2014 Oct; 22(2):293-302. PubMed ID: 25046589
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.